A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay

British Journal of Cancer

Volumn 80, Issue 9, 1999, Pages 1332-1341

  Raymond, E ^a,b   Sun, D ^a   Izbicka, E ^a   Mangold, G ^a   Silvas, E ^a   Windle, B ^a   Sharma, S ^a   Soda, H ^a   Laurence, R ^a   Davidson, K ^a   Von Hoff, D D ^a  

^a CTRC Institute for Drug Development   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chemotherapy; Cisplatin; New telomerase assay; Porphyrin; Telomerase inhibitors; Telomere length

Indexed keywords

ANTINEOPLASTIC AGENT; PORPHYRIN DERIVATIVE; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER MODEL; CELL STRAIN MCF 7; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CISPLATIN; ENZYME INHIBITORS; FEMALE; HUMANS; MICE; MICE, NUDE; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0033026098     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690526     Document Type: Article

References (41)

1. Allsopp RC and Harley CB (1995) Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219: 130-136
2. Bednarck AK, Sahin A, Brenner AJ, Johnston DA and Aldaz CM (1997) Analysis of telomerase activity in breast cancer: positive detection at the in situ breast carcinoma stage. Clin C Res 3: 11-16
3. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569-573
4. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248
5. Burger AM, Double JA and Newell DR (1997) Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur J Cancer 33: 638-644
6. Chadeneau C, Siegel P, Harley CB, Mullet WJ and Bacchetti S (1995) Telomerase activity in normal and malignant murine tissues. Oncogene 11: 893-898
7. Faraoni I, Turriziani M, Masci G, De Vecchis L, Shay JW, Bonmassar E and Graziani G (1997) Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin Cancer Res 3: 579-585
8. Fisher B (1996) Personal contributions to progress in breast cancer research and treatment. Sem Oncol 23: 414-427
9. Gilley D and Blackburn EH (1994) Lack of telomere shortening during senescence in Paramecium. Proc Natl Acad Sci USA 91: 1955-1958
10. Greider CW (1993) Telomerase and telomere-length regulation: lessons from small eukaryotes to mammals. Cold Spring Harbor Symposium on Quantitative Biology 58: 719-723
11. Greider CW (1994) Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet & Development 4: 203-211
12. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bachetti S, Hirte HW, Counter CM, Greider CW et al (1994) Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59: 307-315
13. Harley CB, Vaziri H, Counter CM and Allsopp RC (1992) The telomere hypothesis of cellular aging. Exp Gerontol 27: 375-382
14. Harley CB and Villeponteau B (1995) Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5: 249-255
15. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, EST program A, Bass MB, Arruda I and Robinson MO (1997) A mammalian telomerase-associated protein. Science 275: 973-977
16. Healy KC (1995) Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol Res 7: 121-130
17. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA and Shay JW (1996) Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122
18. Holt SE, Norton JC, Wright WE and Shay JW (1996) Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 18: 237-248
19. Ishibashi T and Lippard SJ (1998) Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci USA 95: 4219-4223
20. Izbieka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, Sun D, Windle BE, Hurley LH and Won Hoff DD (1999) Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res 59: 639-644
21. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
22. Levy MZ, Allsopp RC, Further AB, Greider CW and Harley CB (1992) Telomere end replication problem and cell aging. J Mol Biol 225: 951-960
23. Marcand S, Gilson E and Shore D (1997) A protein-counting mechanism for telomere length regulation in yeast. Science 275: 986-990
24. Piccart M, Raymond E, Aapro M, Eisenhauer EA and Cvitkovic E (1995) Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: current status and future prospects. Eur J Cancer 31A: 1-10
25. Plowman J, Dykes DJ, Hollingshead M, Simpson-Herren L and Alley MC (1997) Human tumor xenograft models in NCI drug development. In: Anticancer Drug Development Guide, Teicher BA (ed), pp. 101-125. Humana Press: Totowa, NJ
26. Price CM (1993) Telomere structure and function. Ind J Biochem Biophys 30: 77-82
27. Prowse KR and Greider CW (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92: 4818-4822
28. Prowse KR, Avilion AA and Greider CW (1993) Identification of a non-processive telomerase activity from mouse cells. Proc Natl Acad Sci USA 90: 1493-1497
29. Raymond E, Sun D, Chen S-F, Windle B and Von Hoff DD (1996) Agents that target telomerase and telomeres. Curr Opin Biotechnol 7: 583-591
30. Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck SG, Sharma A, Izbieka E, Windle B and Von Hoff DD (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann Oncol 8: 1063-1074
31. Shay JW, Van Der Haegen BA, Ying Y and Wright WE (1993a) The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 209: 45-52
32. Shay JW, Wright WE and Werbin H (1993b) Toward a molecular understanding of human breast cancer: a hypothesis. Breast Cancer Res Treat 25: 83-94
33. Shay JW, Brasiskyte D, Ouellette M, Piatyszek MA, Werbin H, Ying Y and Wright WE (1994) Analysis of telomerase and telomeres. In: Methods in Molecular Genetics, Vol. 5, Part C, Genes and Chromosome Analysis. Adolph KW (ed). pp. 263-280. Academic Press: New York
34. Shay JW, Piatyszek MA, Word RA, Gazdar AF, Wright WE, Kim NW, Weinrich SL, Prowse KR, Harley CB, Hiyama E, Hiyama K, Mehle C, Roos G, Sommerfield HJ, Meeker AK and Coffey DS (1995a) You have not heard the end of it: telomeres, time, telomerase and tumors (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res 36, 673
35. Shay JW, Tomlinson G, Pityszek MA and Gollahon LS (1995b) Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li Fraumeni syndrome. Mol Cell Biol 15: 42-432
36. Sun D, Chen S-F and Von Hoff D (1996) A sensitive and rapid assay method of human telomerase using dynabeads. In: 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Lobbezoo MW (ed). pp. 71 (A240). Kluwer: Amsterdam
37. Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, Trent JO, Jenkins TL, Neidle S and Hurley LH (1997) Inhibition of human telomerase by G-Quadruplex-interactive compounds. J Med Chem 40: 2113-2116
38. Thompson B, Salazar M, Sun D, Jenkins T, Neidle S and Hurley L (1996) Telomerase inhibition by G-quartet interactive compounds. In: 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy. Lobbezoo MW (ed) pp. 71 (A243). Kluwer: Amsterdam
39. Tsao J-I, Zhao Y, Lukas J, Yang X, Shah A, Press M and Shibata D (1997) Telomerase activity in normal and neoplastic breast. Clin Cancer Res 3: 627-631
40. Vojta PJ and Barret JC (1995) Genetic analysis of cellular senescene. Biochem Biophys Acta 1242: 29-41
41. Wheelhouse RT, Sun D, Han H, Han FX and Hurley LH (1998) Cationic porphyrins as telomerase inhibitors: the interaction of tetra (N-methyl-4-pyridyl)porphyrine with quadruplex DNA. J Am Chem Soc 120: 3261-3262